期刊文献+

血管内皮生长因子在宫颈鳞癌介入化疗前后的表达比较 被引量:1

Different Expressions of Vascular Endothelial Growth Factor Before and After Interventional Chemotherapy in Patients with Cervical Squamous Carcinoma
下载PDF
导出
摘要 【目的】探讨血管内皮生长因子(VEGF)在宫颈鳞癌发生发展中的作用,观察介入化疗前后的VEGF表达并进一步评价术前介入化疗联合根治术治疗宫颈鳞癌的可行性和有效性。【方法】采用免疫组化的方法对20例宫颈鳞癌,30例宫颈上皮内瘤样病变及20例正常宫颈组织进行VEGF检测。【结果】宫颈鳞癌VEGF阳性表达率(70%)明显高于宫颈上皮内瘤样病变(CIN)(20%)及正常宫颈组织(5%),差异有显著性(P<0.01)。宫颈鳞癌VEGF表达与肿瘤转移、临床分期及组织学分级无明显相关性(P>0.05)。宫颈鳞癌介入化疗前VEGF阳性表达水平以高表达为主,而介入化疗后VEGF阳性表达以低表达为主,差异有显著性(P<0.05)。本组20例宫颈鳞癌患者均行根治性手术,介入化疗后有效率为95%,手术切除率达100%,术后4例患者有淋巴结转移,阴道残端切缘无癌细胞。20例患者均未发生严重介入化疗和手术相关的并发症。【结论】VEGF在宫颈鳞癌组织中呈高表达,从血管生成方面进一步阐述宫颈鳞癌的发生发展,可作为宫颈鳞癌的一种肿瘤指标。术前介入化疗可缩小肿瘤病灶,减少淋巴结转移,且组织中VEGF在宫颈癌介入化疗前后差异有显著性,故认为介入化疗是宫颈鳞癌有效的具有可行性的辅助治疗手段。 [Objective]To study the effect of vascular endothelial growth factor(VEGF) in occurrence and development of cervical squamous carcinoma and the difference of expression of VEGF before and after intraarterial chemotherapy , evaluate the feasibility and efficacy of intra-arterial chemotherapy followed by radical hysterectomy of cervical squamous carcinoma. [Methods]Twenty cases of cervical squamous carcinoma,30 eases of cervical intraepithelial neoplasia(CIN)and 20 cases of normal cervical tissue sample were stained for VEGF by immunohistoehemistry method. [Resuhs]VEGF positive expression rate in cervical squamous carcinoma(70 % ) was significantly higher than that in normal cervical tissue ( 5 %) and CIN (20 %) ( P 〈 0.01 ). VEGF expression was not correlated to metastasis,the clinical stage of the tumor and the grade of histology. VEGF positive expression level in cervical squamous carcinoma before intra arterial chemotherapy was significantly higher than that after radical hysterectomy( P 〈0.05). All patients of cervical squamous carcinoma underwent radical hysterectomy. The total response rate was 95%. The radical hysterectomy rate was 100% ,4 patients had pelvic lymph node metastasis(20%). There were no severe complications related to intra-arterial chemotherapy and radical hysterectomy. [Conclusion]VEGF may be a marker of cervical squamous carcinoma . Intar-arterial chemotherapy before operation can shrink tumor size,decrease the lymph node mcstastasis. So intra-arterial chemotherapy before operation is a feasible and efficacious assistant method with the difference of expression of VEGF before intra-arterial chemotherapy and after operation for cervical squamous carcinoma.
作者 肖辉
机构地区 湖南省肿瘤医院
出处 《医学临床研究》 CAS 2006年第3期350-352,355,共4页 Journal of Clinical Research
关键词 癌.鳞状细胞/药物疗法 宫颈肿瘤/药物疗法 内皮生长因子 carcinoma,squamous cell/DT cervix neoplasms/DT endothelial growth factors
  • 相关文献

参考文献14

二级参考文献20

  • 1赵莲茹,赵文霞,邵铭华,胡玉红,卢北燕,吕晓明,申大光,魏志成.双侧髂内动脉插管灌注化疗法用于晚期恶性肿瘤[J].中华妇产科杂志,1994,29(10):607-609. 被引量:15
  • 2[1]Toshio H,Toshiharu K,Tsunehisa K, et al. Prognostic signifcance of epithelial-stromal vascular cuffing and microvessel in squamous cell carcinoma of the uterine cervix [J].Gynecol Oncol,1999,74(3):369-374. 被引量:1
  • 3[2]Gasparini G, Weidner N, Bevilacqua, et al. Tumor microvessel density, P53 expression,tumorsize and peritumoral lymphatic vessel invasion relevant prognostic markers in node-negative breast carcinoma [J]. J Clincal Oncology, 1994,12(3):454-466. 被引量:1
  • 4[3]Bremer G L, Tiebosch A T, van der Putten H W,et al. Tumor angiogenesis: an independent prognostic parameter in cervical cancer [J]. Am J Obstet Gynecol,1996,174(1):126-131. 被引量:1
  • 5[4]Kaku T, Hirakawa T, Kamura T,et al. Angiogenesis in adenocarcinoma of the uterine cervix Cancer [J], 1998,83(7):1384-1390. 被引量:1
  • 6[5]Guidi A J, Abu-Jawdeh G, Berse B et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia [J]. J Natl Cancer Inst, 1995,16,87(16):1237-1245. 被引量:1
  • 7[6]Tjalma W, Weyler J, Weyn B,et al. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer [J]. Eur J Obstet Gynecol Reprod Biol, 2000,92(2):251-257. 被引量:1
  • 8[7]Kodama J, Seki N, Tokumo K,et al. Vascular endothelial growth factor is implicated in early invasion in cervical cancer [J]. Eur J Cancer, 1999,35(3):485-489. 被引量:1
  • 9Neufeld G,FASEB J,1999年,13卷,922页 被引量:1
  • 10Fong G H,Natrue,1995年,376卷,66页 被引量:1

共引文献61

同被引文献19

  • 1金飞燕.结肠直肠癌治疗药 贝伐单抗(bevacizumab)[J].世界临床药物,2006,27(6):379-379. 被引量:2
  • 2郑秀娟,李淞漪.塞来昔布抑制宫颈癌Hela细胞的研究[J].实用肿瘤学杂志,2007,21(2):120-121. 被引量:4
  • 3Vaidya A P,Parnes A D,Seiden M V.Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies[J].Curt Treat Options Oncol,2005,6(2):103-114. 被引量:1
  • 4Bellone S,Frera G,Landolfi G,et al.Overexpression of epidermal growth factor type-1 receptor(EGF-RI)in cervical cancer:implications for Cetuximab-mediated therapy in recurrent/metastatic disease[J].Gynecol Oncol,2007,106(3):513-520. 被引量:1
  • 5Neri D,Bicknell R.Tumor vascular targeting[J].Nat Rev Cancer,2005,5(6):436-446. 被引量:1
  • 6Zerkowski M P,Camp R L,Burtness B A,et al.Quantitative analysis of breast cancer tissue micmarrays shows high COX-2 expression is associated with poor outcome[J].Cancer Invest,2007,25(1):19-26. 被引量:1
  • 7Lim S C,Lee T B,Choi C H,et al.Expression of cyelooxygenase-2 and its relationship to p53 accumulation in colorectalcancers[J].Yonsei Med J,2007,48(3):495-501.Fujimoto J,Toyoki H,Sato E,et al.Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers[J].J Biomed Sci,2006,13(6):825-832. 被引量:1
  • 8Jiang Y,Goldberg I D,Shi Y E.Complex roles of tissue inhibitors of metalloproteinases in cancer[J].Oncogene,2002,21(14):2245-2252. 被引量:1
  • 9Davidson B,Goldberg I,Kopo lovic J,et al.Expression of matrix metalloprteinase-9 in squamouse cell carcinoma of the uterine cervix-clinicopathologic study using immunohistoche-mistry and mRNA in situ hybridization[J].Gynocol Oncol,1999,72(3):380-386. 被引量:1
  • 10Goncalves A,Fabbro M,Lhommé C,et al.A phaseⅡtrial to evaluate gefitinih as secoud-or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer[J].Gynecol Oncol,2008,108(1):42-46. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部